121 related articles for article (PubMed ID: 2920218)
1. Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects.
Noworolska A; Harłozińska A; Buchegger F; Lawińska B; Richter R
Blut; 1989 Feb; 58(2):69-73. PubMed ID: 2920218
[TBL] [Abstract][Full Text] [Related]
2. Distribution of carbohydrate structures in individual maturation stages of myeloid leukemic cells.
Noworolska A; Slesak B; Harłonzińska A; Richter R
Neoplasma; 1991; 38(1):57-62. PubMed ID: 2011210
[TBL] [Abstract][Full Text] [Related]
3. Non-specific cross-reacting antigen (NCA) in individual maturation stages of myelocytic cell series.
Noworolska A; Harłozińska A; Richter R; Brodzka W
Br J Cancer; 1985 Mar; 51(3):371-7. PubMed ID: 3882113
[TBL] [Abstract][Full Text] [Related]
4. Distribution of surface nonspecific cross-reacting antigen and influence of proteolytic enzymes on this antigen in myeloid cell series.
Noworolska A; Harłozińska-Szmyrka A; Richter R
Cancer Detect Prev; 1986; 9(3-4):365-71. PubMed ID: 3527416
[TBL] [Abstract][Full Text] [Related]
5. Relationship between myelomonocytic, myeloid and nonspecific cross-reacting (NCA) antigens during myelocytic cell differentiation.
Harłozińska A; Noworolska A; Majdic O; Richter R; Kotlarek-Haus S
Br J Cancer; 1987 Dec; 56(6):787-90. PubMed ID: 2449236
[No Abstract] [Full Text] [Related]
6. Antigenic variants of the nonspecific cross-reacting antigen (NCA).
Burtin P; Chavanel G; Hendrick JC; Frenoy N
J Immunol; 1986 Aug; 137(3):839-45. PubMed ID: 2424986
[TBL] [Abstract][Full Text] [Related]
7. An investigation of factors influencing serum NCA (non-specific cross-reacting antigen) level in patients with chronic myeloid leukaemia.
Frénoy N; Ben-Bunant M; Berruel C; Child JA; Gendron MC; Missett JL; Razafimahaleo E; Burtin P
Br J Cancer; 1982 Nov; 46(5):765-72. PubMed ID: 6756460
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a species of non-specific cross-reacting antigen (NCA) expressed by human monocytic cell lines: structure and expression during cell differentiation.
Kuroki M; Yamanaka T; Matsuo Y; Ohtani T; Matsuo Y; Minowada J; Misumi Y; Oikawa S; Nakazato H; Matsuoka Y
Int J Cancer; 1994 Mar; 56(6):886-91. PubMed ID: 8119777
[TBL] [Abstract][Full Text] [Related]
9. Nonspecific cross-reacting antigen 50/90 is elevated in patients with breast, lung, and colon cancer.
Allard WJ; Neaman IE; Elting JJ; Barnett TR; Yoshimura H; Fritsche HA; Yeung KK
Cancer Res; 1994 Mar; 54(5):1227-34. PubMed ID: 8118811
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of pulmonary and pleural neoplasms using a monoclonal antibody (47D10) which reacts with nonspecific cross-reacting antigen.
Radosevich JA; Robinson PG; Carney WP; Warren W; Rosen ST; Gould VE
Tumour Biol; 1989; 10(6):281-8. PubMed ID: 2480629
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody M195: a diagnostic marker for acute myelogenous leukemia.
Scheinberg DA; Tanimoto M; McKenzie S; Strife A; Old LJ; Clarkson BD
Leukemia; 1989 Jun; 3(6):440-5. PubMed ID: 2725060
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of NCA in patients with chronic myelocytic leukemia.
Wahren B; Gahrton G; Rudén U; Hammarström S
Int J Cancer; 1982 Feb; 29(2):133-7. PubMed ID: 6949877
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization of CD66, CD67, and NCA in human neutrophils.
Ducker TP; Skubitz KM
J Leukoc Biol; 1992 Jul; 52(1):11-6. PubMed ID: 1640165
[TBL] [Abstract][Full Text] [Related]
14. Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
Caron PC; Dumont L; Scheinberg DA
Clin Cancer Res; 1998 Jun; 4(6):1421-8. PubMed ID: 9626458
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.
Audette M; Buchegger F; Schreyer M; Mach JP
Mol Immunol; 1987 Nov; 24(11):1177-86. PubMed ID: 3320743
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical demonstration of nonspecific cross-reacting antigen in normal and neoplastic human tissues using a monoclonal antibody. Comparison with carcinoembryonic antigen localization.
Tsutsumi Y; Onoda N; Misawa M; Kuroki M; Matsuoka Y
Acta Pathol Jpn; 1990 Feb; 40(2):85-97. PubMed ID: 2187320
[TBL] [Abstract][Full Text] [Related]
17. Immunoreactivity of anti K562 monoclonal antibodies with leukemic cells of myeloid lineage.
Chiplunkar SV; Maniar HS; Tatake RJ; Amin KM; Advani SH; Gangal SG
Leuk Res; 1990; 14(1):69-75. PubMed ID: 1689437
[TBL] [Abstract][Full Text] [Related]
18. Immunochemical identification of an alpha 1-acid glycoprotein-antigenic determinant on carcinoembryonic antigen (CEA) and non-specific cross-reacting antigen (NCA).
Ochi Y; Ura Y; Hamazu M; Fujiyama Y; Kajita Y; Ishida M; Miyazaki T; Tamura K
Clin Chim Acta; 1984 Mar; 138(1):9-19. PubMed ID: 6201306
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of secondary cytogenetic changes and nonspecific cross-reacting antigen (NCA) in patients with Ph-positive chronic myeloid leukemia.
Haus O; Noworolska A; Laskowski M; Kuliszkiewicz-Janus M; Kozłowska J; Harłozińska-Szmyrka A; Jagielski J; Kotlarek-Haus S
Exp Mol Pathol; 1990 Apr; 52(2):235-42. PubMed ID: 2332039
[TBL] [Abstract][Full Text] [Related]
20. Immunological and biochemical characterization of the nonspecific cross-reacting antigen epitopes using twenty-three monoclonal antibodies.
Kuroki M; Arakawa F; Higuchi H; Haruno M; Wakisaka M; Matsuoka Y
Hybridoma; 1991 Oct; 10(5):557-74. PubMed ID: 1725168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
